Australia markets open in 5 hours 55 minutes

VYNE Therapeutics Inc. (VYNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7250+0.0550 (+2.00%)
As of 02:03PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2221
Avg. Estimate-0.22-0.23-0.9-0.96
Low estimate-0.25-0.25-1-0.96
High estimate-0.19-0.22-0.81-0.96
Year ago EPS-3.09-2.01-2.78-0.9
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1121
Avg. Estimate110k110k450kN/A
Low estimate110k110k400kN/A
High estimate110k110k500kN/A
Year ago sales135k114k424k450k
Sales growth (year/est)-18.50%-3.50%6.10%N/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.99-0.76-0.5-0.24
Actual EPS-3.09-2.01-0.2-0.15
Difference-1.1-1.250.30.09
Surprise %-55.30%-164.50%60.00%37.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.22-0.23-0.9-0.96
7 days ago-0.25-0.25-1-0.96
30 days ago-0.25-0.25-1-0.96
60 days ago-0.25-0.25-1-0.96
90 days ago-0.86-0.86-2.1-2.19
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesVYNEIndustrySector(s)S&P 500
Current qtr.92.90%N/AN/AN/A
Next qtr.88.60%N/AN/AN/A
Current year67.60%N/AN/AN/A
Next year-6.70%N/AN/AN/A
Next 5 years (per annum)215.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A